Manufacturers Life Insurance Company, The Axsome Therapeutics, Inc. Transaction History
Manufacturers Life Insurance Company, The
- $108 Billion
- Q3 2024
A detailed history of Manufacturers Life Insurance Company, The transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 22,623 shares of AXSM stock, worth $1.92 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
22,623
Previous 22,901
1.21%
Holding current value
$1.92 Million
Previous $1.84 Million
10.26%
% of portfolio
0.0%
Previous 0.0%
Shares
26 transactions
Others Institutions Holding AXSM
# of Institutions
325Shares Held
37.7MCall Options Held
912KPut Options Held
855K-
Rtw Investments, LP New York, NY4.19MShares$355 Million6.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4MShares$339 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.3MShares$280 Million0.01% of portfolio
-
Fairmount Funds Management LLC Philadelphia, PA2.36MShares$200 Million34.46% of portfolio
-
Bvf Inc San Francisco, CA1.05MShares$88.7 Million2.99% of portfolio
About Axsome Therapeutics, Inc.
- Ticker AXSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,878,000
- Market Cap $3.64B
- Description
- Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...